Cargando…

Dual contraceptives and associated predictors in HIV positive women: a case–control study

BACKGROUND: People living with the human immune deficiency virus (PLHIV) are an important group to address HIV prevention. Mostly, 90% of the HIV cases in children are usually through mother-to-child transmission. Dual contraception (barrier condoms i.e., male, and female condoms) are one of the mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashore, Alemu, Erkalo, Desta, Prakash, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336104/
https://www.ncbi.nlm.nih.gov/pubmed/35906704
http://dx.doi.org/10.1186/s12978-022-01475-x
_version_ 1784759472814555136
author Ashore, Alemu
Erkalo, Desta
Prakash, Ravi
author_facet Ashore, Alemu
Erkalo, Desta
Prakash, Ravi
author_sort Ashore, Alemu
collection PubMed
description BACKGROUND: People living with the human immune deficiency virus (PLHIV) are an important group to address HIV prevention. Mostly, 90% of the HIV cases in children are usually through mother-to-child transmission. Dual contraception (barrier condoms i.e., male, and female condoms) are one of the most effective ways to avoid HIV transmission. Thus, the present study was carried out to establish the predictors associated with the use of dual contraceptives in sexually active HIV positive women in Hossana, Southern Ethiopia. METHODS: An institution based unmatched case–control study among randomly selected 312 sexually active HIV positive women was conducted from February 2021 to May 2021. The data were collected through structured questionnaire and anti-retroviral treatment (ART) cards considering the case-to-control ratio of 1:3. The information was coded, entered into Epi-Info7.0 and exported to SPSS 20.0 for further analysis. A P-value < 0.25 in bi-variate analysis was further processed for multi-variate analysis and P-value < 0.05 was considered statistically significant. RESULTS: A response rate of 97.2% was recorded. A significant difference was observed towards the use of dual contraceptives in sexually active HIV positive women living in urban vs rural areas (AOR = 0.28; 95% CI = 0.09–0.84), having sexual intercourse with a regular partner (AOR = 3.77; 95% CI = 1.48–9.55) and taking first initiation to use (AOR = 0.05; 95% CI = 0.02–0.11). CONCLUSION: The determinants associated with lower use of dual contraceptives were residing in rural areas, sexual intercourse with a regular partner and low initiation rate at first time for use of dual contraceptives. Therefore, we strongly recommend that open discussion about sexually transmitted infections like HIV and their prevention, providing adequate facilities in rural areas can help to prevent HIV transmission and reduce the disease burden. The health professionals are encouraged to organize awareness campaigns in rural areas for use of dual contraceptives among PLHIV.
format Online
Article
Text
id pubmed-9336104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93361042022-07-30 Dual contraceptives and associated predictors in HIV positive women: a case–control study Ashore, Alemu Erkalo, Desta Prakash, Ravi Reprod Health Research BACKGROUND: People living with the human immune deficiency virus (PLHIV) are an important group to address HIV prevention. Mostly, 90% of the HIV cases in children are usually through mother-to-child transmission. Dual contraception (barrier condoms i.e., male, and female condoms) are one of the most effective ways to avoid HIV transmission. Thus, the present study was carried out to establish the predictors associated with the use of dual contraceptives in sexually active HIV positive women in Hossana, Southern Ethiopia. METHODS: An institution based unmatched case–control study among randomly selected 312 sexually active HIV positive women was conducted from February 2021 to May 2021. The data were collected through structured questionnaire and anti-retroviral treatment (ART) cards considering the case-to-control ratio of 1:3. The information was coded, entered into Epi-Info7.0 and exported to SPSS 20.0 for further analysis. A P-value < 0.25 in bi-variate analysis was further processed for multi-variate analysis and P-value < 0.05 was considered statistically significant. RESULTS: A response rate of 97.2% was recorded. A significant difference was observed towards the use of dual contraceptives in sexually active HIV positive women living in urban vs rural areas (AOR = 0.28; 95% CI = 0.09–0.84), having sexual intercourse with a regular partner (AOR = 3.77; 95% CI = 1.48–9.55) and taking first initiation to use (AOR = 0.05; 95% CI = 0.02–0.11). CONCLUSION: The determinants associated with lower use of dual contraceptives were residing in rural areas, sexual intercourse with a regular partner and low initiation rate at first time for use of dual contraceptives. Therefore, we strongly recommend that open discussion about sexually transmitted infections like HIV and their prevention, providing adequate facilities in rural areas can help to prevent HIV transmission and reduce the disease burden. The health professionals are encouraged to organize awareness campaigns in rural areas for use of dual contraceptives among PLHIV. BioMed Central 2022-07-29 /pmc/articles/PMC9336104/ /pubmed/35906704 http://dx.doi.org/10.1186/s12978-022-01475-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ashore, Alemu
Erkalo, Desta
Prakash, Ravi
Dual contraceptives and associated predictors in HIV positive women: a case–control study
title Dual contraceptives and associated predictors in HIV positive women: a case–control study
title_full Dual contraceptives and associated predictors in HIV positive women: a case–control study
title_fullStr Dual contraceptives and associated predictors in HIV positive women: a case–control study
title_full_unstemmed Dual contraceptives and associated predictors in HIV positive women: a case–control study
title_short Dual contraceptives and associated predictors in HIV positive women: a case–control study
title_sort dual contraceptives and associated predictors in hiv positive women: a case–control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336104/
https://www.ncbi.nlm.nih.gov/pubmed/35906704
http://dx.doi.org/10.1186/s12978-022-01475-x
work_keys_str_mv AT ashorealemu dualcontraceptivesandassociatedpredictorsinhivpositivewomenacasecontrolstudy
AT erkalodesta dualcontraceptivesandassociatedpredictorsinhivpositivewomenacasecontrolstudy
AT prakashravi dualcontraceptivesandassociatedpredictorsinhivpositivewomenacasecontrolstudy